Literature DB >> 9185525

Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin.

S Pastore1, E Fanales-Belasio, C Albanesi, L M Chinni, A Giannetti, G Girolomoni.   

Abstract

Lesional skin of atopic dermatitis (AD) harbors high numbers of dendritic cells with enhanced stimulatory capacity for T lymphocytes. In this study, lesional AD skin was shown to stain heavily in both epidermal and dermal compartments for GM-CSF, a cytokine crucial to dendritic cell functions. Keratinocyte cultures established from uninvolved skin of AD patients exhibited markedly increased spontaneous and PMA-stimulated release of GM-CSF compared with keratinocytes from nonatopic controls. Correspondingly, keratinocytes from AD patients showed higher constitutive as well as PMA-induced GM-CSF gene expression. Larger amounts of GM-CSF were produced by AD keratinocytes, also in response to IL-1alpha, but not after stimulation with LPS, lipoteichoic acid, or staphylococcal enterotoxin B. Hydrocortisone reduced GM-CSF gene expression and protein release in both atopic and control keratinocytes. Supernatants from atopic keratinocytes were able to strongly stimulate PBMC proliferation in a GM-CSF-dependent manner. Moreover, conditioned medium from PMA-treated AD keratinocytes, together with exogenous IL-4, could support phenotypical and functional maturation of peripheral blood precursors into dendritic cells. Enhanced production of GM-CSF by keratinocytes may contribute relevantly to the establishment and chronicity of AD lesions, in particular to the increased number, sustained activation, and enhanced antigen-presenting functions of dendritic cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185525      PMCID: PMC508153          DOI: 10.1172/JCI119496

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Expression of granulocyte/macrophage-colony-stimulating factor, interleukin-8 and RANTES in the bronchial epithelium of mild asthmatics is down-regulated by inhaled beclomethasone dipropionate.

Authors:  R J Davies; J H Wang; C J Trigg; J L Devalia
Journal:  Int Arch Allergy Immunol       Date:  1995 May-Jun       Impact factor: 2.749

2.  Modulation of Ia+ Langerhans cell numbers in vivo by cultured epidermis derived supernatants and by GM-CSF.

Authors:  G M O'Sullivan; R Sluyter; C M Boswell; R S Barnetson; G M Halliday
Journal:  Exp Dermatol       Date:  1996-02       Impact factor: 3.960

3.  Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis.

Authors:  L C Wood; P M Elias; C Calhoun; J C Tsai; C Grunfeld; K R Feingold
Journal:  J Invest Dermatol       Date:  1996-03       Impact factor: 8.551

4.  Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations.

Authors:  D G Marsh; J D Neely; D R Breazeale; B Ghosh; L R Freidhoff; E Ehrlich-Kautzky; C Schou; G Krishnaswamy; T H Beaty
Journal:  Science       Date:  1994-05-20       Impact factor: 47.728

5.  Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.

Authors:  Q Hamid; M Boguniewicz; D Y Leung
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

6.  GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo.

Authors:  S Braunstein; G Kaplan; A B Gottlieb; M Schwartz; G Walsh; R M Abalos; T T Fajardo; L S Guido; J G Krueger
Journal:  J Invest Dermatol       Date:  1994-10       Impact factor: 8.551

7.  Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis.

Authors:  D L Bratton; Q Hamid; M Boguniewicz; D E Doherty; J M Kailey; D Y Leung
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

8.  Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls.

Authors:  S Till; B Li; S Durham; M Humbert; B Assoufi; D Huston; R Dickason; P Jeannin; A B Kay; C Corrigan
Journal:  Eur J Immunol       Date:  1995-10       Impact factor: 5.532

9.  Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate.

Authors:  P Szabolcs; D Avigan; S Gezelter; D H Ciocon; M A Moore; R M Steinman; J W Young
Journal:  Blood       Date:  1996-06-01       Impact factor: 22.113

Review 10.  Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases.

Authors:  D Y Leung
Journal:  J Allergy Clin Immunol       Date:  1995-09       Impact factor: 10.793

View more
  44 in total

1.  Epithelial cells and atopic diseases.

Authors:  G Girolomoni; S Pastore
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

2.  Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

Authors:  P Fraticelli; M Sironi; G Bianchi; D D'Ambrosio; C Albanesi; A Stoppacciaro; M Chieppa; P Allavena; L Ruco; G Girolomoni; F Sinigaglia; A Vecchi; A Mantovani
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

3.  A Novel Endogenous Damage Signal, CSF-2, Activates Multiple Beneficial Functions of Adipose Tissue-Derived Mesenchymal Stem Cells.

Authors:  Se-Ra Park; Ara Cho; Jae-Wan Kim; Hwa-Yong Lee; In-Sun Hong
Journal:  Mol Ther       Date:  2019-03-19       Impact factor: 11.454

4.  [Outside-inside or inside-outside? Impaired skin barrier as a primary defect in atopic eczema].

Authors:  S Kamann; T Ruzicka
Journal:  Hautarzt       Date:  2007-01       Impact factor: 0.751

5.  DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity.

Authors:  David W C Hunt; Iordanka A Ivanova; Lina Dagnino
Journal:  Tissue Barriers       Date:  2020-06-01

6.  Transcriptional control and transcriptomic analysis of lipid metabolism in skin barrier formation and atopic dermatitis (AD).

Authors:  Nilika Bhattacharya; Gitali Ganguli-Indra; Arup K Indra
Journal:  Expert Rev Proteomics       Date:  2019-08-14       Impact factor: 3.940

Review 7.  Animal models of atopic dermatitis.

Authors:  Haoli Jin; Rui He; Michiko Oyoshi; Raif S Geha
Journal:  J Invest Dermatol       Date:  2009-01       Impact factor: 8.551

8.  Role of staphylococcal superantigen in atopic dermatitis: influence on keratinocytes.

Authors:  Kyu Han Kim; Ji Hyun Han; Jin Ho Chung; Kwang Hyun Cho; Hee Chul Eun
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

Review 9.  The genetics of atopic dermatitis.

Authors:  Yin-Hsiu Chien; Wuh-Liang Hwu; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 8.667

10.  Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors.

Authors:  D R Germolec; J Spalding; H S Yu; G S Chen; P P Simeonova; M C Humble; A Bruccoleri; G A Boorman; J F Foley; T Yoshida; M I Luster
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.